Advisory Panel of Experts Endorses FDA Approval of New Alzheimer's Drug
CEOs could easily be replaced with AI, experts argue
World is ill-prepared for breakthroughs in AI, say experts | Governments have made insufficient regulatory progress, ‘godfathers’ of the technology say before summit
